Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial
ContributorsGautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F
Published inClinical lung cancer, vol. 18, no. 3, p. 303-309
Publication date2017
Abstract
Keywords
- Bevacizumab
- Chemotherapy
- Lung cancer
- Maintenance therapy
- Pemetrexed
Affiliation entities
Citation (ISO format)
GAUTSCHI, Oliver et al. Bevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19/09 Trial. In: Clinical lung cancer, 2017, vol. 18, n° 3, p. 303–309. doi: 10.1016/j.cllc.2016.11.007
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:93754
- DOI : 10.1016/j.cllc.2016.11.007
- PMID : 27993482
Journal ISSN1525-7304
